Many investors have sustained significant losses investing in the UBS Carlyle Fund I, LLC and the UBS Carlyle Fund II, LLC sold by UBS Financial Services ("UBS"). Private Placements such as the Carlyle Funds contain significant risks which many investors are unaware of. Furthermore, investors that purchase Private Placements must meet stringent financial requirements in order to be classified as an accredited investor to purchase the funds. Questions remain whether UBS confirmed these financial requirements with their customers and also what UBS knew about the holdings of the funds, as the real estate markets had already begun deteriorating while UBS solicited interest in the funds.
According to The Securities Law Firm of Menzer & Hill, P.A., many of the individuals we speak with have informed us that their Broker-Dealer(s) have led them to believe that Private Placements are safe alternatives to the stock market. Unfortunately, for many of these investors, they've learned that is not the case.
The fact of the matter is many Private Placements contain substantial risks and are not suitable for many investors. Brokerage Firms are soliciting these types of investments because they tend to be some of the most profitable investment products the Broker-Dealer offers.
For those individuals that have sustained investment losses, they have the opportunity to possibly recover their losses through a FINRA arbitration if the Brokerage Firm misrepresented the risks involved with the investment or if the investor was never suitable to purchase the investment in the first place.